NASDAQ:MTFB MOTIF BIO PLC/S (MTFB) Stock Price, News & Analysis → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free MTFB Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.10▼$0.1250-Day Range$0.10▼$0.1152-Week Range$0.08▼$11.50Volume867,698 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get MOTIF BIO PLC/S alerts: Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). About MOTIF BIO PLC/S Stock (NASDAQ:MTFB)Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.Read More Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). MTFB Stock News HeadlinesApril 12, 2024 | tmcnet.comRice Biotech Launch Pad startup Motif Neurotech announces peer-reviewed publication on wireless cortical stimulator for precise neuromodulationFebruary 3, 2024 | msn.comSmall-molecule A485 mobilizes white blood cells on demandApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.November 3, 2023 | finance.yahoo.comROBIT PLC’S FINANCIAL INFORMATION AND ANNUAL GENERAL MEETING IN 2024August 9, 2023 | finance.yahoo.com4GLOBAL plc's (LON:4GBL) Stock Is Going Strong: Have Financials A Role To Play?August 2, 2023 | finance.yahoo.comIs There An Opportunity With Stelrad Group PLC's (LON:SRAD) 44% Undervaluation?June 13, 2023 | finance.yahoo.comDAVA - Endava plcMay 25, 2023 | finance.yahoo.comLacklustre Performance Is Driving NIOX Group Plc's (LON:NIOX) Low P/SApril 26, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.April 27, 2023 | morningstar.comCushman & Wakefield PLC CWK Stock QuoteFebruary 22, 2023 | finance.yahoo.comEvli Plc: Financial Statements Bulletin January-December 2022February 13, 2023 | marketwatch.comEnzyme-Linked Immunosorbent Assay (ELISA) Testing Market Size, Analysis with Key Players having Regional Statistics and Application Forecast to 2029February 13, 2023 | marketwatch.comLuciferase Assay Kits Market Trends and Opportunities and Forecast to 2028 with Top Countries DataFebruary 10, 2023 | wsj.comAccenture PLC Cl ANovember 16, 2022 | finance.yahoo.comConsti Plc's financial reporting and Annual General Meeting in 2023October 20, 2022 | marketwatch.comImmunoprotein Reagents and Assay Kits Market Research on Present State and Future Growth Prospects of Key Players, Forecast by 2022 To 2028October 3, 2022 | fool.co.ukMotif BioAugust 15, 2022 | finance.yahoo.comQ32 Bio and Horizon Therapeutics Announce Collaboration in Autoimmune DiseasesJuly 23, 2022 | apnews.comThe Worldwide Hemoglobin A1c Analyzer Industry is Expected to Reach $627 Million by 2027 - ResearchAndMarkets.comJuly 15, 2022 | yahoo.comManifold Bio's molecular 'barcodes' could break through pharma's in vivo bottleneckSee More Headlines Receive MTFB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MOTIF BIO PLC/S and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:MTFB CUSIPN/A CIK1674657 Webwww.motifbio.com Phone212-210-6248FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesDr. Graham George Lumsden (Age 59)CEO & Exec. Director Mr. Jonathan E. Gold (Age 46)CFO & Exec. Director Dr. David B. Huang (Age 44)Chief Medical Officer Mr. Robert Dickey IV (Age 63)Advisor Laurie DoyleHead of Investor Relations & Corp. CommunicationsKey CompetitorsContext TherapeuticsNASDAQ:CNTXGrifolsNASDAQ:GRFSLAVA TherapeuticsNASDAQ:LVTXMainz BiomedNASDAQ:MYNZNLS PharmaceuticsNASDAQ:NLSPView All Competitors MTFB Stock Analysis - Frequently Asked Questions What other stocks do shareholders of MOTIF BIO PLC/S own? Based on aggregate information from My MarketBeat watchlists, some companies that other MOTIF BIO PLC/S investors own include Sorrento Therapeutics (SRNE), Allergan (AGN), Ampliphi Biosciences (APHB), Neurocrine Biosciences (NBIX), Forward Pharma A/S (FWP), Novartis (NVS), SDX Energy (SDX), Block (SQ) and Adaptimmune Therapeutics (ADAP). When did MOTIF BIO PLC/S IPO? MOTIF BIO PLC/S (MTFB) raised $17 million in an IPO on Friday, November 18th 2016. The company issued 2,400,000 shares at $6.98 per share. H.C. Wainwright & Co. acted as the underwriter for the IPO. This page (NASDAQ:MTFB) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MOTIF BIO PLC/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
